{
  "actions": [
    {
      "acted_at": "2005-10-20",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2005-10-20",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2005-10-20",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2005-11-04",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr4103-109",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    }
  ],
  "congress": "109",
  "cosponsors": [
    {
      "bioguide_id": "D000355",
      "district": "15",
      "name": "Dingell, John D.",
      "original_cosponsor": true,
      "sponsored_at": "2005-10-20",
      "state": "MI",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "R000053",
      "district": "15",
      "name": "Rangel, Charles B.",
      "original_cosponsor": true,
      "sponsored_at": "2005-10-20",
      "state": "NY",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001145",
      "district": "9",
      "name": "Schakowsky, Janice D.",
      "original_cosponsor": true,
      "sponsored_at": "2005-10-20",
      "state": "IL",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S000810",
      "district": "13",
      "name": "Stark, Fortney Pete",
      "original_cosponsor": true,
      "sponsored_at": "2005-10-20",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "W000215",
      "district": "30",
      "name": "Waxman, Henry A.",
      "original_cosponsor": true,
      "sponsored_at": "2005-10-20",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2005-10-20",
  "number": "4103",
  "official_title": "To amend title XVIII of the Social Security Act to provide for improved accountability in the Medicare Advantage and prescription drug programs.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Medicare Advantage and Prescription Drug Accountability Act of 2005",
  "sponsor": {
    "bioguide_id": "B000944",
    "district": "13",
    "name": "Brown, Sherrod",
    "state": "OH",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2005-10-20",
  "subjects": [
    "Access to health care",
    "Auditing",
    "Business records",
    "Coinsurance",
    "Commerce",
    "Congress",
    "Congressional reporting requirements",
    "Consumer complaints",
    "Consumer education",
    "Cost accounting",
    "Drug industry",
    "Drugs",
    "Federal employees",
    "Finance and Financial Sector",
    "Financial statements",
    "Government Operations and Politics",
    "Government contractors",
    "Government employees' health insurance",
    "Government paperwork",
    "Health",
    "Health insurance",
    "Health maintenance organizations",
    "Inspectors general",
    "Insurance premiums",
    "Investments",
    "Legislation",
    "Managed care",
    "Medicaid",
    "Medical economics",
    "Medical fees",
    "Medical statistics",
    "Medicare",
    "Medigap",
    "Ombudsman",
    "Physicians",
    "Prescription pricing",
    "Profit",
    "Social Welfare"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2005-10-20",
    "date": "2005-11-30T20:46:57Z",
    "text": "Medicare Advantage and Prescription Drug Accountability Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to require the contract with an Medicare Advantage (MA) organization to provide for a minimum loss ratio (aggregate average benefits that are at least a minimum ratio of the aggregate average revenues collected under the contract) and a maximum administrative cost ratio (aggregate average administrative costs that do not exceed a maximum ratio of the aggregate average revenues collected under the contract).\n\nRequires each contract with a Medicare+Choice organization to grant the Secretary of Health and Human Services the right to audit and inspect any books and records of the organization for compliance with such ratio and related administrative cost requirements.\n\nApplies such requirements to contracts with prescription drug sponsors under Medicare part D (Voluntary Prescription Drug Benefit Program).\n\nPrescribes requirements for financial transparency of MA plans.\n\nRenders an election to enroll with an MA plan ineffective unless the election form is signed by the individual and specifically acknowledges specified plan features.\n\nApplies such requirements to prescription drug plans under Medicare part D.\n\nDirects the Secretary to transmit to Congress annual MA accountability and prescription drug accountability reports.\n\nRequires periodic audits by the departmental Inspector General of the Secretary's determinations about the acturial equivalency of MA plans.\n\n\n\nRequires each prescription drug plan sponsor with respect to a prescription drug plan, and each MA organization with respect to an MA-PD plan, to report annually to the Inspector General on drug claims rejections and reversals on appeal.\n\nDirects the Secretary to appoint a Medicare prescription drug ombudsman."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Medicare Advantage and Prescription Drug Accountability Act of 2005",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend title XVIII of the Social Security Act to provide for improved accountability in the Medicare Advantage and prescription drug programs.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Medicare Advantage and Prescription Drug Accountability Act of 2005",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-13T04:49:53Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/109/hr/BILLSTATUS-109hr4103.xml"
}